10 Years of Ocrelizumab Treatment in Multiple Sclerosis: Long-term Efficacy and Safety Clinical Trial Data

Authors
Category Primary study
JournalNeurology
Year 2024
This article has no abstract
Epistemonikos ID: c89f72b93597afc68969c184b57942189989fb3c
First added on: Feb 19, 2025